Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.

about

Current Status of Gene Engineering Cell Therapeutics.

P2860

Q49829282-4F671DA3-1666-4D50-A32E-B798611B276C

P2860

Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.

Item

http://www.wikidata.org/entity/Q42371616

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Generation and characterizatio ...... ft tissue sarcoma in children.

@en

Generation and characterizatio ...... ft tissue sarcoma in children.

@nl

type

Item

label

Generation and characterizatio ...... ft tissue sarcoma in children.

@en

Generation and characterizatio ...... ft tissue sarcoma in children.

@nl

prefLabel

Generation and characterizatio ...... ft tissue sarcoma in children.

@en

Generation and characterizatio ...... ft tissue sarcoma in children.

@nl

P1476

Generation and characterizatio ...... ft tissue sarcoma in children.

@en

P2093

Eva Rettinger

http://www.w3.org/2001/XMLSchema#string

Michael Merker

http://www.w3.org/2001/XMLSchema#string

Peter Bader

http://www.w3.org/2001/XMLSchema#string

Sarah Oelsner

http://www.w3.org/2001/XMLSchema#string

Verena Pfirrmann

http://www.w3.org/2001/XMLSchema#string

Winfried S Wels

http://www.w3.org/2001/XMLSchema#string

P2860

Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

Advantages and applications of CAR-expressing natural killer cells

Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy

Adoptive immunotherapy for cancer: harnessing the T cell response

Chimeric antigen receptor T cells for sustained remissions in leukemia

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

P304

66137-66153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19821

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simone Fulda

Thomas Klingebiel

P577

2017-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29029499

http://www.w3.org/2001/XMLSchema#string

P932

5630399

http://www.w3.org/2001/XMLSchema#string

Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.

about

P2860

P2860

Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932